online ISSN 2415-3176
print ISSN 1609-6371
logoExperimental and Clinical Physiology and Biochemistry
J. 2026, 106(2): 89–93

Experimental medicine


Antimicrobial activity of lyophilized dermal xenografts modified with silver nanoparticles

V. V. SULYMA, O. I. CHUPASHKO, M. I. SULYMA, I. V. KOVALENKO, T. M. RUMYNSKA, I. V. STOIANOVSKYI

Received: 15-06-2026

Accepted: 23-09-2026

Published: 28-09-2026

Abstract

Abstract. Background and aim. The management of wounds of various etiologies complicated by infectious processes remains a key challenge in modern surgery. While lyophilized dermal xenografts are effective temporary coverings that reduce plasma loss and protect against secondary contamination, their collagen matrix lacks intrinsic antimicrobial activity. It can serve as a substrate for bacterial colonization. Therefore, modern strategies necessitate the modification of these dressings with antibacterial agents, such as silver nanoparticles (AgNPs).

Materials and Methods. A standardized 6-step chemical reduction protocol was utilized to integrate silver into the dermal matrix. The process included tissue saturation with 0.1 % AgNO 3 , formation of a stable [Ag(NH 3 ) 2 ] + complex, and reduction using 0.1 % ascorbic acid. Antimicrobial activity was evaluated via the agar diffusion method against a broad spectrum of reference and clinical strains, including S. aureus, P. aeruginosa, and Candida spp. Identification was confirmed using MALDI-TOF MS.

Results. Physicochemical calculations established that the protocol ensures a silver deposition of 0.3175 mg/cm², which is therapeutically effective yet remains within the safe threshold for topical application. In vitro testing revealed pronounced antimicrobial activity, with zones of inhibition ranging from 15 to 19 mm for Gram-positive bacteria and up to 18 mm for P. aeruginosa. The modified grafts also demonstrated significant fungicidal properties. Based on consumption rate calculations, the matrix-deposited silver provides sustained bactericidal action for approximately 6–7 days, even under high bacterial bioburden (10 7 CFU/cm 2 ).

Conclusions. The developed 6-stage chemical reduction methodology provides a therapeutically sound concentration of silver nanoparticles within the xenomatrix. The modified grafts exhibit high bactericidal and fungicidal efficacy and offer a prolonged duration of action that outperforms standard silver-based ointments, making them a promising solution for burn and purulent surgery.

Keywords: lyophilized dermal xenografts, silver nanoparticles, chemical reduction, wound infection, antimicrobial activity, in vitro study

Full text: PDF (Eng)

References
  1. Chen J, Li Y, Dan W, Dan N. In situ construction of a chitosan-based antibacterial barrier on acellular dermal matrix for infected wound healing. Biomacromolecules. 2023;24(12):5745-5757. doi.org/10.1021/acs.biomac.3c00824
  2. Nather A, Siow W, Thambiah J, Goh J. Lyophilized skin xenografts: Preparation, sterilization, and clinical application in extensive wound defects. Cell and Tissue Banking. 008;9(3):191–199. doi.org/10.1007/s10561-008-9067-x
  3. Alven S, Aderibigbe BA. Acellular Dermal Matrices and Co-Polymers for Wound Healing Applications. Int J Mol Sci. 2020;21(23):9287. doi.org/10.3390/ijms21239287
  4. Alven S, Aderibigbe BA. Nanomaterials-incorporated biopolymer-based wound dressings for the treatment of infected wounds. Polymers. 2024;16(3):421. doi.org/10.3390/polym16030421
  5. Tottoli EM, Dorati R, Genta I, Chiesa E, Pisani S, Conti B. Beneficial Effect of Wound Dressings Containing Silver and Silver Nanoparticles in Wound Healing–From Experimental Studies to Clinical Practice. Life. 2022;12(1):69. doi.org/10.3390/life12010069
  6. Dakal TC, Kumar A, Majumdar RS, Yadav V. Mechanistic basis of antimicrobial actions of silver nanoparticles. Front Microbiol. 2016;7:1831. doi.org/10.3389/fmicb.2016.01831
  7. Gavriliu S, Lungu MV, Enescu DM, Georgescu FL, Vasilescu M, Trandafir V, et al. Evaluation of therapeutic silver concentrations in collagen-based biomaterials for wound treatment.J Mater Sci Mater Med. 2021;32(10):124. doi.org/10.1007/s10856-021-06603-z
  8. Balaure NI, Grumezescu AM. Role of Silver Nanoparticles in Wound Healing: Mechanisms, Efficacy, and Clinical Applications. Inorganics. 2025;13(12):401. doi.org/10.3390/inorganics13120401
  9. Kadam VV, Shaiwale NS, Shanti Krishna V, Gaikwad SL, Patil AB, Bodas D, et al. In situ synthesis of silver nanoparticles on collagen matrix using gallic acid for wound healing applications. Int J Biol Macromol. 2019;123:883–893. doi.org/10.1016/j.ijbiomac.2018.11.168
  10. Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: A review. J Pharm Anal. 2016;6(2):71–79. doi.org/10.1016/j.jpha.2015.11.005
  11. European Committee on Antimicrobial Susceptibility Testing. Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST. Version 8.0, 2020 [Internet]. Växjö: EUCAST; 2020 [cited 2026 Jun 15]. Available from: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/QC/v_8.0_EUCAST_QC_Tables.pdf
  12. Ansary HE, Abdel-Aziz MM, El-Saber Batiha G. Determination of minimum inhibitory concentration (MIC) of silver nanoparticles against major wound pathogens. J Drug Deliv Sci Technol.2021;61:102127. doi.org/10.1016/j.jddst.2020.102127
  13. Multani MS, Khan S, AlShehri BM, Alshahrani MM. Pseudomonas aeruginosa in burn wounds: Pathogenesis, multi-drug resistance, and therapeutic challenges. Burns. 2022;48(5):1033-1045. doi.org/10.1016/j.burns.2022.01.015
  14. Radulescu M, Ficai D, Oprea O, Ficai A, Andronescu E, Holban AM. Diffusion characteristics of metallic nanoparticles immobilized in structured protein hydrogels and agar media. Materials. 2020;13(9):2145. doi.org/10.3390/ma13092145


Програмування - Roman.im | QR-Code Generator